Mirae Asset Global Investments
RIGL icon

Mirae Asset Global Investments’s Rigel Pharmaceuticals RIGL Stock Holding History

Mirae Asset Global Investments’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$32.4K Sell
827
-120
-13% -$3.7K ﹤0.01% 1422
2026
Q1 		$25.6K Buy
947
+65
+7% +$2.18K ﹤0.01% 1400
2025
Q4 		$37.8K Buy
882
+189
+27% +$7.13K ﹤0.01% 1452
2025
Q3 		$19.6K Buy
693
+3
+0.4% +$90 ﹤0.01% 1497
2025
Q2 		$12.9K Buy
690
+101
+17% +$1.92K ﹤0.01% 1453
2025
Q1 		$10.5K Buy
589
+2
+0.3% +$41 ﹤0.01% 1465
2024
Q4 		$9.69K Buy
+587
New +$11.3K ﹤0.01% 1517

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Mirae Asset Global Investments's RIGL Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Rigel Pharmaceuticals (RIGL) stake by 13% in Q2 2026, selling an estimated $3.7K and leaving 827 shares worth $32.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1422.

Mirae Asset Global Investments first reported a position in RIGL in Q4 2024 and has held it in 7 quarters since. The position peaked at $37.8K in Q4 2025. 46 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • Mirae Asset Global Investments held 827 shares of Rigel Pharmaceuticals worth $32.4K as of Q2 2026.
  • Mirae Asset Global Investments sold 120 Rigel Pharmaceuticals shares in Q2 2026, an estimated $3.7K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1422 holding.
  • Mirae Asset Global Investments first reported a position in Rigel Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Mirae Asset Global Investments's Rigel Pharmaceuticals position peaked at $37.8K in Q4 2025.
  • 46 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.